Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

The content, links, and pdfs are no longer maintained and might be outdated.

  • The content on this page is being archived for historic and reference purposes only.
  • For current, updated information see the MMWR website.

Appendix A: Conflicts of Interest

External Work Group Members

Miriam Alter, PhD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Sanjeev Arora, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

Consultancy:

Served on Advisory Board of Vertex Pharmaceuticals in 2009

Grants/Grants Pending:

Grants from Vertex Pharmaceuticals, Roche/ Genentech, Gilead, Zyrnogenetics, Bristol Myers, Pharmasett, and Abbott paid to institution for clinical trials

Lectures/ Speakers Bureaus:

Scherring Corp., served on September Bureau for Roche Pharmaceuticals until mid-2009

Bruce Bacon, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Doug Campos-Outcalt, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Alfred DeMaria, Jr., MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Janet Durfee, MSN

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Yngve Falck-Ytter, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Colleen Flanigan, MS

For the work under consideration:

Support for Travel:

CDC Foundation

Other relevant financial activities:

No financial conflict of interest reported

Marc Ghany, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Robert Gish, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

Board Membership:

Hepahope

Consultancy:

Performed as a consultant to Abbott, Anadys Pharmaceuticals, Inc., Bayer AG, Bristol-Myers Squibb Company, Durect, Hepahope, Hoffman-LaRoche Ltd., Genentech, Gilead Sciences, GlaxoSmithKline, GlobeImmune, Human Genome Sciences, Merck, Metabasis Therapeutics, OSI/Astellas Parmasset, Schering-Plough Corporation, Three Rivers Pharma, VitalTherapies, and ZymoGenetics; payments directed to an SPF fund for research and education.

Lectures/ Speakers Bureaus:

Speakers bureau activities for Bayer, Bristol-Myers Squibb Company, F. Hoffman-LaRoche Ltd., Gilead Sciences, Inc., GlaxoSmithKline, Onyx, Merck/Schering-Plough Corporation, Three Rivers, Salix, SciClone Pharmaceuticals focused on HBV, HCV, and liver cancer, specifically epidemiology, diagnosis, and treatment, with additional program presentations for HBV and management of complications of cirrhosis; has a speakers contract to do promotional talks for BMS, Roche, Schering-Plough, Gilead Sciences, Bayer and Onyx; payments are directed to an SPF fund for research and education.

Grants/ Grants Pending:

Support from Bayer-Onyx, Bristol-Myers Squibb Company, Genentech/ F. Hoffman-LaRoche, Ltd., Gilead Sciences, Genentech, Pharmasset, Zymogenetics; payments directed to an institutional fund under contract to CPMC.

Stock/ Stock Options:

Major stock shareholder for Hepahope

Fasiha Kanwal, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Emmett Keeffe, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

Consultancy:

Vertex

Travel/ Accommodations:

Vertex

Kathleen Koechlin, PhD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Cameron Lewis

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Jake Liang, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Robert Lubran, MPA

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Iris Mabry-Hernandez, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Katherine McGlynn, PhD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Barbara McGovern, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

Employment:

Editor at UpToDate

Other:

Editor at Infectious Diseases Society of America

Rachel McLean, MPH

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Michael Ninburg

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

Consultancy:

Vertex, Abbott, Genentech, GlaxoSmithKline, Merck, Hoffman LaRoche, Tibotec, Boehringer Ingelheim

Grants/ Grants Pending:

Grants from Vertex, Merck, Genentech, Hoffman La Roche, Schering Plough, Gilead, Novartis, and Human Genome Sciences paid to institution

Payment for the Development of Educational Presentations:

Vertex, Hoffmann La Roche, and Schering Plough, paid to institution

Phillip Reichert, MPH

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Vinod Rustgi, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

Consultancy:

Merck, Vertex

Grants/ Grants Pending:

Grants from BMS, Gilead, Anadys, Boehringer-Ingelheim-Abbott paid to institution

Lectures/ Speakers Bureaus:

Merck, Vertex, Genentech, Gilead, Onyx

Lorren Sandt

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

Consultancy:

Abbott, for community advisory board and paid to institution

Grants/ Grants Pending:

Unrestricted educational grants from Vertex, Merck, and Genentech paid to institution; Conference grant from Gilead paid to institution

Travel/ Accommodations:

Money for travel from BMS, Vertex, Boehringer Ingelheim, Merck, Genentech/Roche and Tibotec for community advisory boards and paid to institution

Gloria Searson

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Anne Spaulding, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

Consultancy:

Georgia Correctional Healthcare; clinical consultant for hepatitis and HIV care

Grants/ Grants Pending:

Grant support from DHHS, CDC, HRSA, and indirectly from NIH paid to institution

Lectures/ Speakers Bureaus:

Hepatitis Foundation International, Albany Medical College

Donna Sweet, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

Grants/ Grants Pending:

Pfizer, BMS Pharmaceuticals

Lectures/ Speakers Bureaus:

Abbott, BMS, Boehringer Ingelheim, Tibotec, Gilead

Andrew Talal, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

Board Membership:

Merck & Co., Genentech/Roche, Boehringer Ingelheim, Pfizer, Bayer/ Onyx, Vertex

Consultancy:

Merck & Co., Genentech

Grants/ Grants Pending:

Merck & Co., Vertex, Boehringer-Ingelheim, and Genentech/Roche, Pfizer, Bayer/Onyx paid to institution

Lectures/ Speakers Bureaus:

Vertex and Genentech/ Roche

Payment for Development of Educational Presentations:

Merck & Co., Medscape

Litjen Tan, PhD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Chris Taylor

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

Grants/ Grants Pending:

Vertex, Gilead, OraSure, Merck & Co., Janssen, BMS paid to institution

Travel/ Accommodations:

Vertex, OraSure

Lisa Townshend-Bulson, MSN

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

Expert Testimony:

CDC Cooperative Agreement with ANTHC, paid to institution

Tam Van

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Kathleen Whitaker, PhD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Richard Wild, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

John Wong, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

CDC Work Group Members

Geoff Beckett, MPH

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Scott Holmberg, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Deborah Holtzman, PhD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Rebecca Morgan, MPH

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Dan Riedford, JD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Bryce Smith, PhD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Philip Spradling, MD

For the work under cocnsideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

Chong-Gee Teo, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported

John W. Ward, MD

For the work under consideration:

No financial conflict of interest reported

Other relevant financial activities:

No financial conflict of interest reported



Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #